We're still accepting applications for fall 2025!
Heinze K, Cairns ES, Thornton S, et al. The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. Clin Cancer Res. 2023 Sep 1;29(17):3471-3483. doi: 10.1158/1078-0432.CCR-22-3815
Kang EY, Weir A, Meagher NS, et al. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. Cancer. 2023 Mar 1;129(5):697-713. doi: 10.1002/cncr.34582
Meagher NS, Hamilton P, Milne K, et al. Profiling the immune landscape in mucinous ovarian carcinoma. Gynecol Oncol. 2023;168:23-31. doi:10.1016/j.ygyno.2022.10.022
Garsed DW, Pandey A, Fereday S, et al. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. Nat Genet. 2022;54(12):1853-1864. doi:10.1038/s41588-022-01230-9
Phung MT, Webb PM, DeFazio A, et al. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecol Oncol. 2023;168:68-75. doi:10.1016/j.ygyno.2022.10.018
Phung MT, Alimujiang A, Berchuck A, et al. Reproductive Factors Do Not Influence Survival with Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2022;31(4):909-913. doi:10.1158/1055-9965.EPI-21-1091
Brieger KK, Phung MT, Mukherjee B, et al. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev. 2022;31(2):443-452. doi:10.1158/1055-9965.EPI-21-0977
Hanley GE, Kaur P, Berchuck A, et al. Cardiovascular medications and survival in people with ovarian cancer: A population-based cohort study from British Columbia, Canada. Gynecol Oncol. 2021;162(2):461-468. doi:10.1016/j.ygyno.2021.05.021
Saner FAM, Herschtal A, Nelson BH, et al. Going to extremes: determinants of extraordinary response and survival in patients with cancer. Nat Rev Cancer. 2019;19(6):339-348. doi:10.1038/s41568-019-0145-5
Millstein J, Budden T, Goode EL, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Ann Oncol. 2020;31(9):1240-1250. doi:10.1016/j.annonc.2020.05.019
Brieger KK, Peterson S, Lee AW, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecol Oncol. 2020;158(3):702-709. doi:10.1016/j.ygyno.2020.06.481
Minlikeeva AN, Cannioto R, Jensen A, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes Control. 2019;30(5):537-547. doi:10.1007/s10552-019-01157-3
Clarke CL, Kushi LH, Chubak J, et al. Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients. Cancer Epidemiol Biomarkers Prev. 2019;28(5):996-999. doi:10.1158/1055-9965.EPI-18-1324
Alimujiang A, Khoja L, Wiensch A, et al. "I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival. Gynecol Oncol. 2019;155(3):461-467. doi:10.1016/j.ygyno.2019.10.007
Praestegaard C, Jensen A, Jensen SM, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer. 2017;140(11):2422-2435. doi:10.1002/ijc.30600
Dixon SC, Nagle CM, Wentzensen N, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. Br J Cancer. 2017;116(9):1223-1228. doi:10.1038/bjc.2017.68
Minlikeeva AN, Freudenheim JL, Eng KH, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1470-1473. doi:10.1158/1055-9965.EPI-17-0367
Epidemiology Working Group Steering Committee, Ovarian Cancer Association Consortium Members of the EWG SC, in alphabetical order:, Doherty JA, Jensen A, et al. Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. J Natl Cancer Inst. 2017;109(10):djx144. doi:10.1093/jnci/djx144
Cannioto RA, LaMonte MJ, Kelemen LE, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. Br J Cancer. 2016;115(1):95-101. doi:10.1038/bjc.2016.153
Nagle CM, Dixon SC, Jensen A, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer. 2015;113(5):817-826. doi:10.1038/bjc.2015.245
